Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene

Sirisak Chanprasert, Jing Wang, Shao Wen Weng, Gregory M. Enns, Daniel R. Boué, Brenda L. Wong, Jerry R. Mendell, Deborah A. Perry, Zarife Sahenk, William J. Craigen, Francisco J Climent Alcala, Juan M. Pascual, Serge Melancon, Victor Wei Zhang, Fernando Scaglia, Lee Jun C Wong

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Mitochondrial DNA (mtDNA) depletion syndromes (MDSs) are a clinically and molecularly heterogeneous group of mitochondrial cytopathies characterized by severe mtDNA copy number reduction in affected tissues. Clinically, MDSs are mainly categorized as myopathic, encephalomyopathic, hepatocerebral, or multi-systemic forms. To date, the myopathic form of MDS is mainly caused by mutations in the TK2 gene, which encodes thymidine kinase 2, the first and rate limiting step enzyme in the phosphorylation of pyrimidine nucleosides. We analyzed 9 unrelated families with 11 affected subjects exhibiting the myopathic form of MDS, by sequencing the TK2 gene. Twelve mutations including 4 novel mutations were detected in 9 families. Skeletal muscle specimens were available from 7 out of 11 subjects. Respiratory chain enzymatic activities in skeletal muscle were measured in 6 subjects, and enzymatic activities were reduced in 3 subjects. Quantitative analysis of mtDNA content in skeletal muscle was performed in 5 subjects, and marked mtDNA content reduction was observed in each. In addition, we outline the molecular and clinical characteristics of this syndrome in a total of 52 patients including those previously reported, and a total of 36 TK2 mutations are summarized. Clinically, hypotonia and proximal muscle weakness are the major phenotypes present in all subjects. In summary, our study expands the molecular and clinical spectrum associated with TK2 deficiency.

Original languageEnglish (US)
Pages (from-to)153-161
Number of pages9
JournalMolecular Genetics and Metabolism
Volume110
Issue number1-2
DOIs
StatePublished - Sep 2013

Fingerprint

Thymidine Kinase
Mitochondrial DNA
Genes
Mutation
Muscle
Skeletal Muscle
Pyrimidine Nucleosides
Phosphorylation
Muscle Hypotonia
Muscle Weakness
Electron Transport
Myopathic Form Mitochondrial DNA Depletion Syndrome
Tissue
Phenotype
Enzymes
Chemical analysis

Keywords

  • Myopathic mtDNA depletion syndrome
  • Thymidine kinase 2 gene

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene. / Chanprasert, Sirisak; Wang, Jing; Weng, Shao Wen; Enns, Gregory M.; Boué, Daniel R.; Wong, Brenda L.; Mendell, Jerry R.; Perry, Deborah A.; Sahenk, Zarife; Craigen, William J.; Alcala, Francisco J Climent; Pascual, Juan M.; Melancon, Serge; Zhang, Victor Wei; Scaglia, Fernando; Wong, Lee Jun C.

In: Molecular Genetics and Metabolism, Vol. 110, No. 1-2, 09.2013, p. 153-161.

Research output: Contribution to journalArticle

Chanprasert, S, Wang, J, Weng, SW, Enns, GM, Boué, DR, Wong, BL, Mendell, JR, Perry, DA, Sahenk, Z, Craigen, WJ, Alcala, FJC, Pascual, JM, Melancon, S, Zhang, VW, Scaglia, F & Wong, LJC 2013, 'Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene', Molecular Genetics and Metabolism, vol. 110, no. 1-2, pp. 153-161. https://doi.org/10.1016/j.ymgme.2013.07.009
Chanprasert, Sirisak ; Wang, Jing ; Weng, Shao Wen ; Enns, Gregory M. ; Boué, Daniel R. ; Wong, Brenda L. ; Mendell, Jerry R. ; Perry, Deborah A. ; Sahenk, Zarife ; Craigen, William J. ; Alcala, Francisco J Climent ; Pascual, Juan M. ; Melancon, Serge ; Zhang, Victor Wei ; Scaglia, Fernando ; Wong, Lee Jun C. / Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene. In: Molecular Genetics and Metabolism. 2013 ; Vol. 110, No. 1-2. pp. 153-161.
@article{1ea29fb229f64f6a89c21e24c4fc1275,
title = "Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene",
abstract = "Mitochondrial DNA (mtDNA) depletion syndromes (MDSs) are a clinically and molecularly heterogeneous group of mitochondrial cytopathies characterized by severe mtDNA copy number reduction in affected tissues. Clinically, MDSs are mainly categorized as myopathic, encephalomyopathic, hepatocerebral, or multi-systemic forms. To date, the myopathic form of MDS is mainly caused by mutations in the TK2 gene, which encodes thymidine kinase 2, the first and rate limiting step enzyme in the phosphorylation of pyrimidine nucleosides. We analyzed 9 unrelated families with 11 affected subjects exhibiting the myopathic form of MDS, by sequencing the TK2 gene. Twelve mutations including 4 novel mutations were detected in 9 families. Skeletal muscle specimens were available from 7 out of 11 subjects. Respiratory chain enzymatic activities in skeletal muscle were measured in 6 subjects, and enzymatic activities were reduced in 3 subjects. Quantitative analysis of mtDNA content in skeletal muscle was performed in 5 subjects, and marked mtDNA content reduction was observed in each. In addition, we outline the molecular and clinical characteristics of this syndrome in a total of 52 patients including those previously reported, and a total of 36 TK2 mutations are summarized. Clinically, hypotonia and proximal muscle weakness are the major phenotypes present in all subjects. In summary, our study expands the molecular and clinical spectrum associated with TK2 deficiency.",
keywords = "Myopathic mtDNA depletion syndrome, Thymidine kinase 2 gene",
author = "Sirisak Chanprasert and Jing Wang and Weng, {Shao Wen} and Enns, {Gregory M.} and Bou{\'e}, {Daniel R.} and Wong, {Brenda L.} and Mendell, {Jerry R.} and Perry, {Deborah A.} and Zarife Sahenk and Craigen, {William J.} and Alcala, {Francisco J Climent} and Pascual, {Juan M.} and Serge Melancon and Zhang, {Victor Wei} and Fernando Scaglia and Wong, {Lee Jun C}",
year = "2013",
month = "9",
doi = "10.1016/j.ymgme.2013.07.009",
language = "English (US)",
volume = "110",
pages = "153--161",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "1-2",

}

TY - JOUR

T1 - Molecular and clinical characterization of the myopathic form of mitochondrial DNA depletion syndrome caused by mutations in the thymidine kinase (TK2) gene

AU - Chanprasert, Sirisak

AU - Wang, Jing

AU - Weng, Shao Wen

AU - Enns, Gregory M.

AU - Boué, Daniel R.

AU - Wong, Brenda L.

AU - Mendell, Jerry R.

AU - Perry, Deborah A.

AU - Sahenk, Zarife

AU - Craigen, William J.

AU - Alcala, Francisco J Climent

AU - Pascual, Juan M.

AU - Melancon, Serge

AU - Zhang, Victor Wei

AU - Scaglia, Fernando

AU - Wong, Lee Jun C

PY - 2013/9

Y1 - 2013/9

N2 - Mitochondrial DNA (mtDNA) depletion syndromes (MDSs) are a clinically and molecularly heterogeneous group of mitochondrial cytopathies characterized by severe mtDNA copy number reduction in affected tissues. Clinically, MDSs are mainly categorized as myopathic, encephalomyopathic, hepatocerebral, or multi-systemic forms. To date, the myopathic form of MDS is mainly caused by mutations in the TK2 gene, which encodes thymidine kinase 2, the first and rate limiting step enzyme in the phosphorylation of pyrimidine nucleosides. We analyzed 9 unrelated families with 11 affected subjects exhibiting the myopathic form of MDS, by sequencing the TK2 gene. Twelve mutations including 4 novel mutations were detected in 9 families. Skeletal muscle specimens were available from 7 out of 11 subjects. Respiratory chain enzymatic activities in skeletal muscle were measured in 6 subjects, and enzymatic activities were reduced in 3 subjects. Quantitative analysis of mtDNA content in skeletal muscle was performed in 5 subjects, and marked mtDNA content reduction was observed in each. In addition, we outline the molecular and clinical characteristics of this syndrome in a total of 52 patients including those previously reported, and a total of 36 TK2 mutations are summarized. Clinically, hypotonia and proximal muscle weakness are the major phenotypes present in all subjects. In summary, our study expands the molecular and clinical spectrum associated with TK2 deficiency.

AB - Mitochondrial DNA (mtDNA) depletion syndromes (MDSs) are a clinically and molecularly heterogeneous group of mitochondrial cytopathies characterized by severe mtDNA copy number reduction in affected tissues. Clinically, MDSs are mainly categorized as myopathic, encephalomyopathic, hepatocerebral, or multi-systemic forms. To date, the myopathic form of MDS is mainly caused by mutations in the TK2 gene, which encodes thymidine kinase 2, the first and rate limiting step enzyme in the phosphorylation of pyrimidine nucleosides. We analyzed 9 unrelated families with 11 affected subjects exhibiting the myopathic form of MDS, by sequencing the TK2 gene. Twelve mutations including 4 novel mutations were detected in 9 families. Skeletal muscle specimens were available from 7 out of 11 subjects. Respiratory chain enzymatic activities in skeletal muscle were measured in 6 subjects, and enzymatic activities were reduced in 3 subjects. Quantitative analysis of mtDNA content in skeletal muscle was performed in 5 subjects, and marked mtDNA content reduction was observed in each. In addition, we outline the molecular and clinical characteristics of this syndrome in a total of 52 patients including those previously reported, and a total of 36 TK2 mutations are summarized. Clinically, hypotonia and proximal muscle weakness are the major phenotypes present in all subjects. In summary, our study expands the molecular and clinical spectrum associated with TK2 deficiency.

KW - Myopathic mtDNA depletion syndrome

KW - Thymidine kinase 2 gene

UR - http://www.scopus.com/inward/record.url?scp=84882856237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882856237&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2013.07.009

DO - 10.1016/j.ymgme.2013.07.009

M3 - Article

C2 - 23932787

AN - SCOPUS:84882856237

VL - 110

SP - 153

EP - 161

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 1-2

ER -